TUESDAY, Jan. 11, 2022 (HealthDay News) — It’s a move that could severely limit the number of people taking the controversial new Alzheimer’s drug Aduhelm: Medicare on Tuesday proposed to only cover the cost of the pricey medication for people enrolled in approved clinical trials. A final decision on coverageContinue Reading

TUESDAY, Jan. 11, 2022 (HealthDay News) — For several years, a leading U.S. pediatricians’ group has called for middle and high schools to start later in the morning, to help these young people get the right amount of sleep. Now, new research suggests that students aren’t the only ones whoContinue Reading

TUESDAY, Jan. 11, 2022 (HealthDay News) — Secondhand vapor from electronic cigarettes is harmful to others, causing bronchitis symptoms and shortness of breath in young bystanders, a new study reports. Secondhand exposure to vapor increased teens’ risk of bronchitis symptoms by 40% and shortness of breath by 53%, according toContinue Reading

MONDAY, Jan. 10, 2022 (HealthDay News) — Medicare has been told to reassess a significant premium increase it had announced that largely stemmed from the expensive new Alzheimer’s drug Aduhelm. U.S. Health and Human Services Secretary Xavier Becerra’s directive, which was announced on Monday, comes shortly after Aduhelm maker BiogenContinue Reading

MONDAY, Jan. 10, 2022 (HealthDay News) — More than 30 years after passage of the landmark Americans with Disabilities Act (ADA), many doctors still don’t know how to provide accessible care, a new study finds. “Despite the fact people with disabilities comprise 25% of the population, they often confront barriersContinue Reading